RDI Partners is a national market leader in structuring and delivering compliant, low-cost Australian R&D incentive solutions for foreign-controlled groups that seek to establish a presence in Australia.
As a long-standing, award-winning advisory firm, RDI Partners provide an end-to-end, 'one-stop-shop' solution incorporating company set-up, corporate, tax, international tax/transfer pricing, resident director and R&D incentive services through a single, integrated team and point of contact.
Across more than 2,000 R&D tax registrations, RDI Partners has supported over $1 billion in Australian R&D and innovation investment.
Objectives
- Connecting with clinical stage biotech entities looking to conduct future clinical development activities in Australia
- Assisting clinical stage biotech entities benefiting from the quality, speed and cost benefits offered through the application of Australian R&D incentives, including the 43.5% Australian Government R&D Tax Incentive